Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematological effects associated with beta-lactam use.

L M Babiak, M J Rybak

    Drug Intelligence & Clinical Pharmacy
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections.

    Antimicrobial agents and chemotherapy·2019
    Same author

    Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

    Antimicrobial agents and chemotherapy·2017
    Same author

    Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis.

    Antimicrobial agents and chemotherapy·2014
    Same author

    Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA.

    Antimicrobial agents and chemotherapy·2013
    Same author

    Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2013
    Same author

    Successful treatment of a left ventricular assist device infection with daptomycin non-susceptible methicillin-resistant Staphylococcus aureus: case report and review of the literature.

    Transplant infectious disease : an official journal of the Transplantation Society·2012
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Beta-lactam antibiotics, while effective, can cause dangerous bleeding issues by affecting platelet function and blood clotting. Careful patient monitoring and dose adjustments are crucial to prevent these life-threatening hematological side effects.

    Area of Science:

    • Pharmacology
    • Hematology
    • Infectious Diseases

    Background:

    • Beta-lactam antibiotics are widely used for anti-infective therapy.
    • Newer beta-lactams offer broader spectrum and better pharmacokinetics.
    • They are often favored over more toxic antibiotic options.

    Purpose of the Study:

    • To investigate the hematological side effects of beta-lactam antibiotics.
    • To highlight the potential for life-threatening bleeding complications.

    Main Methods:

    • Review of hematological effects associated with beta-lactam use.
    • Analysis of platelet function and coagulation cascade inhibition.
    • Monitoring of bleeding times, prothrombin time, and activated partial thromboplastin time.

    Related Experiment Videos

    Main Results:

    • Beta-lactams can inhibit normal platelet function.
    • Coagulation cascade may be impaired, affecting clotting.
    • Observed effects include altered bleeding times and prolonged clotting assays.

    Conclusions:

    • Beta-lactam antibiotics can induce significant hematological effects, including bleeding risks.
    • Close patient monitoring for bleeding risk factors is essential.
    • Dosage adjustments may mitigate drug-induced hematological problems.